Search

Search Constraints

You searched for: Author/Creator Pant, Shubham

Search Results

31. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

32. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

33. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. Issue 2 (23rd October 2020)

34. First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors. (April 2021)

36. Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. (9th June 2020)

40. PARTNER: An open-label, randomized, phase 2 study of docetaxel/cisplatin chemotherapy with or without panitumumab as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck. (October 2016)